Background:
Obstructive sleep apnea (OSA) is a worldwide increasing syndrome, which, by promoting endothelial dysfunction, contributes to extend the cardiovascular risk. We evaluated the cardiovascular risk in a group of OSA patients.
Methods:
A total of 185 OSA subjects (19 normal weight, 57 overweight, 109 obese), who entered the Ambulatory of Sleep Disorders of the Institute of Respiratory Diseases of the University of Bari, during 1 year, were enrolled in the study. We assessed anthropometric features, polysomnographic findings, cardiovascular risk factors, smoking habit, Pulmonary Function Test, Arterial Blood Gas Analysis, Epworth Questionnaire, and Charlson Co-morbidities Index (CCI). Subjects were divided into three groups, according to their BMI: individuals with BMI ≥30 kg/m (Group 1 n = 109, mean age 61 ± 1; 74.3% men), individuals with BMI ranging from 25.0 to 29.9 kg/m defined as overweight subjects (Group 2 n = 57, mean age 58.8 ± 1.4; 77% men), and subjects with a BMI ranging from 18.5 to 24.9 kg/m defined as normal weight subjects (Group 3 n = 19, mean age 54.2 ± 2.3; 64,2% men).
Results:
In the whole population, the percentage cardiovascular risk was weakly related with BMI (r = 0.33; P < .001), but not with AHI. The cardiovascular risk was strictly related to the obesity (P < .00002), while the Epworth Questionnaire score and the Charlson Co-morbidity Index were respectively statistically higher in the group of obese individuals (P = .004, P = .0002) than in the other two sub-groups. When AHI values were stratified in tertiles, the percentage cardiovascular risk did not vary with increasing AHI values (Figure 2).
Conclusions:
Further studies are required to investigate the pivotal role of inflammation resulting from obesity, and underlying increased cardiovascular risk in OSA patients.
Citing Articles
One Year Follow-Up Assessment of Impact of Rigorous Diet Regimen and Adequate C-PAP Therapy on Obese Patients with Obstructive Sleep Apnea Syndrome: A Retrospective Study.
Carratu P, Dragonieri S, Quaranta V, Resta O, Portincasa P, Palmieri V
J Clin Med. 2024; 13(21).
PMID: 39518499
PMC: 11546787.
DOI: 10.3390/jcm13216360.
The impact of continuous positive airway pressure therapy on cardiovascular events in patients with obstructive sleep apnoea: an updated systematic review and meta-analysis.
Feng G, Zhuge P, Zhang Z, Ma J
Sleep Breath. 2024; 28(5):2095-2105.
PMID: 39083193
DOI: 10.1007/s11325-024-03107-z.
Obstructive Sleep Apnea Syndrome and Obesity Indicators, Circulating Blood Lipid Levels, and Adipokines Levels: A Bidirectional Two-Sample Mendelian Randomization Study.
Zhang Y, Wang H, Yang J, Wang S, Tong W, Teng B
Nat Sci Sleep. 2024; 16:573-583.
PMID: 38827393
PMC: 11143989.
DOI: 10.2147/NSS.S460989.
Cardiovascular Outcome in Patients with Major Depression: Role of Obstructive Sleep Apnea Syndrome, Insomnia Disorder, and COMISA.
Hein M, Wacquier B, Conenna M, Lanquart J, Point C
Life (Basel). 2024; 14(5).
PMID: 38792664
PMC: 11123427.
DOI: 10.3390/life14050644.
Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among Hypertensive Patients.
Li Y, Shataer R, Chen Y, Zhu X, Sun X
Med Sci Monit. 2024; 30:e942667.
PMID: 38771735
PMC: 11127607.
DOI: 10.12659/MSM.942667.
Characterisation of Symptom and Polysomnographic Profiles Associated with Cardiovascular Risk in a Sleep Clinic Population with Obstructive Sleep Apnoea.
Kemp E, Sutherland K, Bin Y, Chan A, Dissanayake H, Yee B
Nat Sci Sleep. 2024; 16:461-471.
PMID: 38737461
PMC: 11086425.
DOI: 10.2147/NSS.S453259.
Is COPD the Determinant Factor for Myocardial Injury and Cardiac Wall Stress in OSA Patients?.
Voulgaris A, Archontogeorgis K, Apessos I, Paxinou N, Nena E, Steiropoulos P
Medicina (Kaunas). 2023; 59(10).
PMID: 37893477
PMC: 10608258.
DOI: 10.3390/medicina59101759.
Sleep Apnea Combined with Pulmonary Hypertension in a Veteran Patient Population.
Stark P, Chang E
J Clin Med. 2023; 12(14).
PMID: 37510749
PMC: 10380333.
DOI: 10.3390/jcm12144634.
Association between obstructive sleep apnea and resistant hypertension: systematic review and meta-analysis.
Ahmed A, Nur S, Xiaochen Y
Front Med (Lausanne). 2023; 10:1200952.
PMID: 37332747
PMC: 10272746.
DOI: 10.3389/fmed.2023.1200952.
The link between the sphingolipid rheostat and obstructive sleep apnea.
Horvath P, Budi L, Hammer D, Varga R, Losonczy G, Tarnoki A
Sci Rep. 2023; 13(1):7675.
PMID: 37169814
PMC: 10175248.
DOI: 10.1038/s41598-023-34717-4.
Association between obstructive sleep apnea and cardiovascular diseases.
Li Y, Ren J
Acta Biochim Biophys Sin (Shanghai). 2022; 54(7):882-892.
PMID: 35838200
PMC: 9828315.
DOI: 10.3724/abbs.2022084.
Obstructive Sleep Apnea and Cardiovascular Risk: The Role of Dyslipidemia, Inflammation, and Obesity.
Zdravkovic M, Popadic V, Klasnja S, Milic N, Rajovic N, Divac A
Front Pharmacol. 2022; 13:898072.
PMID: 35784707
PMC: 9240428.
DOI: 10.3389/fphar.2022.898072.
Modified Haller index validation and correlation with left ventricular strain in a cohort of subjects with obesity and without overt heart disease.
Sonaglioni A, Nicolosi G, Trevisan R, Granato A, Zompatori M, Lombardo M
Intern Emerg Med. 2022; 17(7):1907-1919.
PMID: 35753022
DOI: 10.1007/s11739-022-03026-5.
Relationships between Obstructive Sleep Apnea Syndrome and cardiovascular risk in a naïve population of southern Italy.
Carratu P, Di Ciaula A, Dragonieri S, Ranieri T, Ciccone M, Portincasa P
Int J Clin Pract. 2021; 75(12):e14952.
PMID: 34610197
PMC: 9285080.
DOI: 10.1111/ijcp.14952.